Understanding how acetaldehyde contributes to oral cancer from alcohol consumption
Dissecting the role of acetaldehyde in oral carcinogenesis
This study is looking at how a substance called acetaldehyde, which comes from drinking alcohol, might cause oral cancer, especially in people who have certain genetic traits or conditions that make it harder for their bodies to handle this substance.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10913440 on NIH RePORTER |
What this research studies
This research investigates the role of acetaldehyde, a byproduct of ethanol metabolism, in the development of oral cancers. It aims to uncover the mechanisms by which acetaldehyde interacts with DNA, leading to mutations that can cause cancer. The study will focus on individuals with genetic variations that affect their ability to detoxify acetaldehyde, as well as those with conditions like Fanconi Anemia that impair DNA repair. By analyzing DNA damage in the oral cavity compared to blood, the research seeks to clarify the unique risks posed by alcohol consumption in the mouth.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults who consume alcohol, particularly those with genetic predispositions affecting acetaldehyde metabolism or individuals with conditions like Fanconi Anemia.
Not a fit: Patients who do not consume alcohol or have no genetic risk factors for acetaldehyde metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies and targeted interventions for individuals at higher risk of oral cancer due to alcohol consumption.
How similar studies have performed: Previous studies have shown a direct link between alcohol consumption and DNA damage in the oral cavity, indicating that this research builds on established findings rather than exploring a completely novel area.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Balbo, Silvia — University of Minnesota
- Study coordinator: Balbo, Silvia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.